Financhill
Back

Kymera Therapeutics Stock Predictions

Kymera Therapeutics Stock Forecast

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 13.2% based on the past 4 years of stock performance.
  • Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Kymera Therapeutics Stock Undervalued?
    The current Kymera Therapeutics [KYMR] share price is $44.98. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Kymera Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 13.2% based on the past 4 years of stock performance.

Kymera Therapeutics Stock Rating

Buy
62
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics overpriced?

  • Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Kymera Therapeutics Stock Price History

Is KYMR stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com

52-Week Data

52-Week High:
53.27
52-Week Low:
18.89

Prediction Charts

Market Cap:
2.91B
Price in USD:
44.98
Volume:
559.06K
Beta:
2.19

Technical Analysis

SMA50:
46.95
SMA100:
45.26
SMA200:
40.89
52-Wk Change:
127.86%

Stock Predictions

  • Is Kymera Therapeutics stock public?
    Yes, Kymera Therapeutics is a publicly traded company.
  • What is the Kymera Therapeutics stock quote today?
    The Kymera Therapeutics stock price is 44.98 USD today.
  • How to buy Kymera Therapeutics stock online?
    You can buy Kymera Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 46.98 47.69 48.88 46.35
Nov-6 49.93 49.52 51.14 48.47
Nov-7 49.52 49.86 50.99 48.58
Nov-8 49.91 50.94 51.13 49.39
Nov-11 51.97 51.83 53.23 51.45
Nov-12 51.49 50.05 52.49 49.12
Nov-13 50.79 48.63 51.15 48.63
Nov-14 48.70 45.95 49.09 45.89
Nov-15 45.00 41.96 45.45 41.50
Nov-18 42.03 42.41 43.08 41.12
Nov-19 42.09 42.84 42.89 41.50
Nov-20 42.75 44.05 44.11 42.10
Nov-21 44.05 43.51 44.81 42.87
Nov-22 43.70 44.98 45.94 43.28

Kymera Therapeutics Earnings

Kymera Therapeutics Earnings Report: Per Share Kymera Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Kymera Therapeutics Forecast Revenue Growth

Kymera Therapeutics Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.51 per share.

* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.